Long-term analysis of intravitreal brolucizumab in recalcitrant cases of chronic central serous retinopathy complicated by neovascularization (pachychoroid neovasculopathy)

Purpose: To assess the long-term safety and efficacy of intravitreal brolucizumab (Pagenax®) in eyes with chronic central serous chorioretinopathy (CSC) complicated by neovascularization (pachychoroid neovasculopathy) refractory to prior therapies. Methods: In this single-center retrospective case s...

Повний опис

Бібліографічні деталі

Автори:	Lalit Verma, Shweta Singh, Dinesh Talwar, Avnindra Gupta, Gauri Khare, Obuli N Ramachandran, Bhanupriya, Gaganjeet Singh Gujral, H S Harish, Nikita Gupta
Формат:	Artigo
Мова:	Inglês
Опубліковано:	Wolters Kluwer Medknow Publications 2026-06-01
Серія:	Indian Journal of Ophthalmology
Предмети:	anti-vegf brolucizumab chronic central serous retinopathy intravitreal pachychoroid neovasculopathy pro-re-nata
Онлайн доступ:	https://journals.lww.com/10.4103/IJO.IJO_2032_25
Теги:	Додати тег Немає тегів, Будьте першим, хто поставить тег для цього запису!